Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling. (Q38827843)
Jump to navigation
Jump to search
scientific article published on 17 April 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling. |
scientific article published on 17 April 2017 |
Statements
Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling (English)
Ming Gu
Shiying Zhang
Yuanyuan Zhao
Jinwen Huang
Yahui Wang
Yin Li
Shengjie Fan
Guang Ji